Latest Articles

Publication Date
Nanoceria as a non-steroidal anti-inflammatory drug for endometriosis theranostics.

Endometriosis, the growth of endometrial-like tissue outside the uterus, causes chronic pain and infertility in 10 % of reproductive-aged women worldwide. Unfortunately, no permanent cure exists, and current medical and …

Published: Dec. 30, 2024, midnight
Surface Molecular Markers for the Isolation of Viable Fibroblast Subpopulations in the Female Reproductive Tract: A Comprehensive Review.

Advancements in single-cell analyzis technologies, particularly single-cell RNA sequencing (scRNA-seq) and Fluorescence-Activated Cell Sorting (FACS), have enabled the analyzis of cellular diversity by providing resolutions that were not available previously. …

Published: Dec. 30, 2024, midnight
Proteomics International Laboratories Ltd (ASX:PIQ) Breakthrough Results for Endometriosis Diagnostic Blood Test - ABN Newswire

Proteomics International Laboratories Ltd (ASX:PIQ) Breakthrough Results for Endometriosis Diagnostic Blood Test ABN Newswire

Published: Dec. 29, 2024, 10:22 p.m.
Assessment of ovarian reserve function in patients with adenomyosis and ovarian endometriosis by three-dimensional transvaginal ultrasound and Anti-Müllerian hormone.

We evaluated the impact of adenomyosis and ovarian endometriosis on ovarian reserve function through transvaginal three-dimensional ultrasound and anti-mullerian hormone testing. A total of 150 female patients who were admitted …

Published: Dec. 28, 2024, midnight
Global, regional, and national prevalence and disability-adjusted life-years for endometriosis in 204 countries and territories, 1990-2019: Findings from a global burden of disease study.

This study aimed to analyze the worldwide, regional burden of endometriosis and its trends from 1990 to 2019, utilizing the latest data from Global Burden of Disease (GBD) 2019. GBD …

Published: Dec. 28, 2024, midnight
Aspira Women's Health in Shelton to use $10M grant to create blood test to detect endometriosis - CTPost

Aspira Women's Health in Shelton to use $10M grant to create blood test to detect endometriosis CTPost

Published: Dec. 27, 2024, 5:33 p.m.
TEFM facilitates uterine corpus endometrial carcinoma progression by activating ROS-NFκB pathway - Journal of Translational Medicine

TEFM facilitates uterine corpus endometrial carcinoma progression by activating ROS-NFκB pathway Journal of Translational Medicine

Published: Dec. 27, 2024, 1:02 p.m.
Dyspareunia and Biomarkers: A Case Study of Sexual Dysfunction in Moderate Endometriosis.

Endometriosis, a chronic hormone-dependent condition affecting 10% of women globally, impacts pelvic organs and occasionally distant sites, causing pain, infertility, and sexual dysfunction. Biomarkers such as IL-8, IL-10, and BDNF …

Published: Dec. 27, 2024, midnight
Recent Trends in Medical Management of Endometriosis.

Endometriosis affects about 10 percent women in the reproductive age group globally and approximately 42 million in India. Managing the patient's pain symptoms associated with endometriosis appears to be the …

Published: Dec. 26, 2024, midnight
Visual-Numeric Endometriosis Scoring System (VNESS) for mapping surgical findings: A validation study.

Several endometriosis classification systems have been proposed and published but the search for a universal language that communicates the complexity, laterality and severity of this disease continues. The authors introduce …

Published: Dec. 25, 2024, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!